MX2012007412A - Composicion portadora. - Google Patents
Composicion portadora.Info
- Publication number
- MX2012007412A MX2012007412A MX2012007412A MX2012007412A MX2012007412A MX 2012007412 A MX2012007412 A MX 2012007412A MX 2012007412 A MX2012007412 A MX 2012007412A MX 2012007412 A MX2012007412 A MX 2012007412A MX 2012007412 A MX2012007412 A MX 2012007412A
- Authority
- MX
- Mexico
- Prior art keywords
- carrier composition
- present
- formulated
- formulation
- relatively high
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composición portadora de la presente invención comprende un compuesto fosfato de un agente de transferencia de electrones y una concentración relativamente alta de un solvente prótico polar. Se puede formular un compuesto biológicamente activo con una composición portadora de la presente invención para proporcionar una formulación.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28950709P | 2009-12-23 | 2009-12-23 | |
PCT/AU2010/001719 WO2011075775A1 (en) | 2009-12-23 | 2010-12-22 | Carrier composition |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012007412A true MX2012007412A (es) | 2012-07-17 |
Family
ID=44194821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012007412A MX2012007412A (es) | 2009-12-23 | 2010-12-22 | Composicion portadora. |
Country Status (16)
Country | Link |
---|---|
US (2) | US20120202780A1 (es) |
EP (1) | EP2516011B1 (es) |
JP (1) | JP5841062B2 (es) |
KR (1) | KR20120107963A (es) |
CN (1) | CN102686279B (es) |
AU (1) | AU2010336018B2 (es) |
BR (1) | BR112012015682A2 (es) |
CA (1) | CA2785242A1 (es) |
ES (1) | ES2643643T3 (es) |
IL (1) | IL220490A0 (es) |
MX (1) | MX2012007412A (es) |
NZ (1) | NZ600773A (es) |
RU (1) | RU2577233C2 (es) |
SG (1) | SG181808A1 (es) |
WO (1) | WO2011075775A1 (es) |
ZA (1) | ZA201204369B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10071030B2 (en) | 2010-02-05 | 2018-09-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
BR112012024835A2 (pt) | 2010-03-30 | 2016-06-07 | Phosphagenics Ltd | adesivo de distribuição transdérmica |
EP2685992A4 (en) | 2011-03-15 | 2014-09-10 | Phosphagenics Ltd | AMINO-QUINOLINES AS KINASE INHIBITORS |
JP6449554B2 (ja) * | 2014-03-30 | 2019-01-09 | 小林製薬株式会社 | 外用医薬組成物 |
KR20190032265A (ko) * | 2015-12-09 | 2019-03-27 | 포스파제닉스 리미티드 | 약제학적 제형 |
US10973761B2 (en) | 2015-12-09 | 2021-04-13 | Phosphagenics Limited | Pharmaceutical formulation |
WO2017143360A1 (en) * | 2016-02-18 | 2017-08-24 | Drabinsky Michael Earl | Treatment for microbial borne illness |
KR102647670B1 (ko) | 2016-12-21 | 2024-03-15 | 아베초 바이오테크놀로지 리미티드 | 방법 |
WO2024090634A1 (ko) * | 2022-10-28 | 2024-05-02 | 주식회사 오가시스 | κ-오피오이드 수용체의 아고니스트를 포함하는 피부 미백용 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2657526B1 (fr) * | 1990-01-31 | 1994-10-28 | Lvmh Rech | Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues. |
AUPR549901A0 (en) * | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
CN100396287C (zh) * | 2000-11-14 | 2008-06-25 | 生命健康科学有限公司 | 含有电子转移剂磷酸盐衍生物的制剂 |
CN1547475B (zh) * | 2001-07-27 | 2010-12-15 | 生命健康科学有限公司 | 含电子转移试剂的磷酸酯衍生物的皮肤制剂 |
CA2466536C (en) * | 2001-12-13 | 2012-02-07 | Vital Health Sciences Pty Ltd | Transdermal transport of compounds |
AU2002950713A0 (en) * | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
FR2846651B1 (fr) * | 2002-10-30 | 2006-06-16 | Rhodia Polyamide Intermediates | Procede de fabrication d'acides carboxyliques |
MXPA05007278A (es) * | 2003-01-17 | 2005-09-30 | Vital Health Sciences Pty Ltd | Compuestos que tienen propiedades anti-proliferativas. |
ES2557475T3 (es) * | 2005-06-17 | 2016-01-26 | Vital Health Sciences Pty Ltd. | Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones |
RU2373957C2 (ru) * | 2006-10-13 | 2009-11-27 | Александр Метталинович Тишин | Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его |
-
2010
- 2010-12-22 BR BR112012015682A patent/BR112012015682A2/pt not_active IP Right Cessation
- 2010-12-22 AU AU2010336018A patent/AU2010336018B2/en active Active
- 2010-12-22 KR KR1020127015752A patent/KR20120107963A/ko not_active Application Discontinuation
- 2010-12-22 WO PCT/AU2010/001719 patent/WO2011075775A1/en active Application Filing
- 2010-12-22 CA CA2785242A patent/CA2785242A1/en not_active Abandoned
- 2010-12-22 US US13/501,494 patent/US20120202780A1/en not_active Abandoned
- 2010-12-22 NZ NZ600773A patent/NZ600773A/en unknown
- 2010-12-22 SG SG2012045183A patent/SG181808A1/en unknown
- 2010-12-22 MX MX2012007412A patent/MX2012007412A/es not_active Application Discontinuation
- 2010-12-22 RU RU2012126143/15A patent/RU2577233C2/ru not_active IP Right Cessation
- 2010-12-22 ES ES10838415.7T patent/ES2643643T3/es active Active
- 2010-12-22 EP EP10838415.7A patent/EP2516011B1/en active Active
- 2010-12-22 JP JP2012545015A patent/JP5841062B2/ja active Active
- 2010-12-22 CN CN201080058887.XA patent/CN102686279B/zh active Active
-
2012
- 2012-06-14 ZA ZA2012/04369A patent/ZA201204369B/en unknown
- 2012-06-18 IL IL220490A patent/IL220490A0/en unknown
-
2016
- 2016-07-25 US US15/218,719 patent/US20160331838A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2516011B1 (en) | 2017-07-12 |
CA2785242A1 (en) | 2011-06-30 |
KR20120107963A (ko) | 2012-10-04 |
IL220490A0 (en) | 2012-08-30 |
ES2643643T3 (es) | 2017-11-23 |
AU2010336018A1 (en) | 2012-07-05 |
JP5841062B2 (ja) | 2016-01-06 |
EP2516011A1 (en) | 2012-10-31 |
BR112012015682A2 (pt) | 2019-09-24 |
ZA201204369B (en) | 2013-02-27 |
RU2012126143A (ru) | 2014-01-27 |
SG181808A1 (en) | 2012-07-30 |
AU2010336018B2 (en) | 2015-10-01 |
CN102686279A (zh) | 2012-09-19 |
EP2516011A4 (en) | 2013-07-03 |
NZ600773A (en) | 2014-04-30 |
WO2011075775A1 (en) | 2011-06-30 |
CN102686279B (zh) | 2015-07-15 |
US20120202780A1 (en) | 2012-08-09 |
US20160331838A1 (en) | 2016-11-17 |
RU2577233C2 (ru) | 2016-03-10 |
JP2013515012A (ja) | 2013-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012007412A (es) | Composicion portadora. | |
BR112012019508A2 (pt) | composição de veículo | |
MX2011008204A (es) | Metodos para reducir la proliferacion y viabilidad de los agentes microbianos. | |
CR20120635A (es) | Compuestos heterocìclicos de nitrògeno ùtiles como inhibidores de pde10 | |
WO2011056961A3 (en) | Method and compositions for suppression of aging | |
ECSP099694A (es) | Derivados de sulfonil amida para el tratamiento del crecimiento celular anormal | |
UY33801A (es) | COMPUESTOS SUSTITUIDOS DE N-(1H-INDAZOL-4IL)IMIDAZO[1,2-a]PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA TIROSINA QUINASA RECEPTORA DE TIPO III | |
CL2013000250A1 (es) | Compuestos conjugados de dimeros de pirrolo[1,4]benzodiazepina; procedimiento de preparacion; y su uso como agente anticanceroso. | |
MX2015007497A (es) | Composiciones de recubrimiento a base de lignina. | |
WO2010056378A3 (en) | Extracellular matrix compositions for the treatment of cancer | |
MX2013001493A (es) | Composiciones orales que comprenden un compuesto de cinc y un agente anti-microbiano. | |
BR112012022774A2 (pt) | Composição sólida compreendendo primeira e segunda dispersões sólidas amorfas | |
GEP20146122B (en) | Pharmaceutical composition | |
MX2013002932A (es) | Formulaciones agricolas liquidas de estabilidad mejorada. | |
GEP20156242B (en) | 2-arylimidazole derivatives as pde10a enzyme inhibitors | |
GEP20156346B (en) | Imidazole derivatives as pde10a enzyme inhibitors | |
MY163311A (en) | A coating composition | |
PE20141410A1 (es) | 3,4 dihidro 1h[1,8] naftiridinonas antibacterianas sustituidas con ciclopenta [c] pirrol | |
MX358616B (es) | Catalizador de expansion. | |
UA100394C2 (en) | Lipoic acid pellet composition | |
MX340868B (es) | Composicion de formulacion agroquimica. | |
NZ628148A (en) | Mitigation of alternate bearing | |
MX336742B (es) | Inhibidores de amida hidrolasa de acido graso. | |
MX2012012951A (es) | Derivados de tris (2-hidroxifenil) metanos, su preparacion y uso. | |
WO2011047277A3 (en) | Release of agents from cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |